Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Neuroprotective Effects of ACTH4-10PRO8-GLY9-PRO10 on The Ketamine-Induced Neurotoxicity In Neonatal Rats: Increased BDNF Expression And BDNF Serum Concentrations


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05648526

Organisation Name: Universitas Sumatera Utara

Overal Status: Completed

Start Date: August 1, 2021

Last Update: December 13, 2022

Lead Sponsor: Universitas Sumatera Utara

Brief Summary: The compound ACTH4-10Pro8-Gly9-Pro10 is a synthetic analog molecule of an adrenocorticotropic hormone (ACTH) short fragment. That is free from hormonal effects and has neuromodulatory effects. We investigate the neuroprotective effects of ACTH4-10Pro8-Gly9-Pro10 can lessen neurotoxicity against ketamine in neonatal rats by looking at BDNF expression in the cortex and hippocampus tissue as well as BDNF blood levels.

Conditions:
  • Ketamine-Induced Neurotoxicity


Total execution time in seconds: 0.20602321624756